Education
About Us
Working with TipRanks
Follow Us
Merck & Company (MRK)
NYSE:MRK
Total Valuation
Merck & Company has a market cap or net worth of $206.72B. The enterprise value is $225.73B.
Market Cap$206.72B
Enterprise Value$225.73B
Share Statistics
Merck & Company has 2,497,783,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,497,783,200
Owned by Insiders0.05%
Owned by Institutions13.15%
Financial Efficiency
Merck & Company’s return on equity (ROE) is 0.37 and return on invested capital (ROIC) is 19.03%.
Return on Equity (ROE)0.37
Return on Assets (ROA)0.15
Return on Invested Capital (ROIC)19.03%
Return on Capital Employed (ROCE)0.23
Revenue Per Employee879.01K
Profits Per Employee234.70K
Employee Count73,000
Asset Turnover0.55
Inventory Turnover2.49
Valuation Ratios
The current PE Ratio of Merck & Company is 12.8. Merck & Company’s PEG ratio is ―.
PE Ratio12.8
PS Ratio0.00
PB Ratio0.00
Price to Fair Value5.44
Price to FCF0.00
Price to Operating Cash Flow9.67
PEG Ratio―
Income Statement
In the last 12 months, Merck & Company had revenue of 64.17B and earned 17.12B in profits. Earnings per share was 6.74.
Revenue64.17B
Gross Profit48.98B
Operating Income20.22B
Pretax Income19.94B
Net Income17.12B
EBITDA25.71B
Earnings Per Share (EPS)6.74
Cash Flow
In the last 12 months, operating cash flow was 7.01B and capital expenditures -2.28B, giving a free cash flow of 4.73B billion.
Operating Cash Flow7.01B
Free Cash Flow4.73B
Free Cash Flow per Share1.89
Dividends & Yields
Merck & Company pays an annual dividend of $0.81, resulting in a dividend yield of 3.8%
Dividend Per Share$0.81
Dividend Yield3.8%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.44
52-Week Price Change-23.42%
50-Day Moving Average80.97
200-Day Moving Average87.54
Relative Strength Index (RSI)60.31
Average Volume (3m)11.79M
Important Dates
Merck & Company upcoming earnings date is Oct 30, 2025, Before Open (Confirmed).
Last Earnings DateJul 30, 2025
Next Earnings DateOct 30, 2025
Ex-Dividend DateSep 15, 2025
Financial Position
Merck & Company as a current ratio of 1.36, with Debt / Equity ratio of 72.09%
Current Ratio1.36
Quick Ratio1.15
Debt to Market Cap0.15
Net Debt to EBITDA0.93
Interest Coverage Ratio15.91
Taxes
In the past 12 months, Merck & Company has paid 2.80B in taxes.
Income Tax2.80B
Effective Tax Rate0.14
Enterprise Valuation
Merck & Company EV to EBITDA ratio is 10.73, with an EV/FCF ratio of 15.24.
EV to Sales4.30
EV to EBITDA10.73
EV to Free Cash Flow15.24
EV to Operating Cash Flow12.84
Balance Sheet
Merck & Company has $9.23B in cash and marketable securities with $34.84B in debt, giving a net cash position of $25.62B billion.
Cash & Marketable Securities$9.23B
Total Debt$34.84B
Net Cash$25.62B
Net Cash Per Share$10.26
Tangible Book Value Per Share$3.29
Margins
Gross margin is 80.96%, with operating margin of 31.51%, and net profit margin of 26.68%.
Gross Margin80.96%
Operating Margin31.51%
Pretax Margin31.07%
Net Profit Margin26.68%
EBITDA Margin40.06%
EBIT Margin33.05%
Analyst Forecast
The average price target for Merck & Company is $101.53, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$101.53
Price Target Upside20.57% Upside
Analyst ConsensusModerate Buy
Analyst Count17
Revenue Growth Forecast2.00%
EPS Growth Forecast20.01%